Tel-Aviv Sourasky medical center
Tel Aviv, 6423906, Israel
NCT Number: NCT03547713
The purpose of this study is to characterize neuropsychological mechanisms (positive affect, negative affect and self-evaluation) mediating processing of social feedback in people with different levels of social anxiety, by implementing functional and structural MRI.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Tel Aviv, 6423906, Israel
Social anxiety (SA) disorder is a relatively widespread emotional disorder which is associated with considerable impairment in social, educational, and occupational functioning (Kessler et al., 2005). This condition is characterized by a debilitating preoccupation with the evaluation of the self by others, ultimately leading to excessive fear and avoidance of interpersonal encounters. As opposed to healthy individuals who typically process social feedback in a positively biased manner, Individuals with high levels of SA tend to evaluate the feedback conveyed by others negatively. Such biases have a profound contribution to the maintenance of social-related concerns (Clark & Wells, 1995).
Thus, the overreaching goal of this research is to provide a neuropsychological account of biased processing of social feedback evident in SA. To meet this goal, participants varying in their level of SA are asked to deliver a speech and evaluate it before and after receiving social feedback during an fMRI scan. Additional structural and resting-state fMRI scans, as well as physiological and psychological measures, are obtained throughout the experiment in order to explain individual differences in processing of feedback. fMRI tasks probing basic neuropsychological processes include a self-referential paradigm, wherein participants judge if different traits varying in valence and social domain (power vs. affiliation) are descriptive of them; a reward vs. punishment task, in which participants can win or lose money; and an emotional reactivity task, in which participants view faces with different emotional expressions.
The long-term goal of this study is to better delineate both neurobiological and psychological models of SA, as well as to help in directing future neuromodulation-based treatments of mood and anxiety disorders.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Social feedback regarding performance of a public speech is delivered to participants
Exposure to traits varying in valence (positive vs. negative) and social domain (power vs. affiliation)
Reception of monetary gains vs. losses
Exposure to emotional faces vs. shapes
Time frame: 1 day
Rating of a public performance made on a 0-10 scale before vs. after reception of social feedback
Time frame: 1 day
2.A. Processing of self-descriptive traits differing in valence (positive vs. negative) and social domain (power vs. affiliation).
2.B. Response to emotional faces. 2.C. Anticipating and receiving monetary reward vs. loss. 3. Brain functional connectivity obtained during resting-state scans obtained at three time-points: a) before the speech; b) before feedback reception; c) after feedback reception.
Time frame: 1 day
b1. Processing of self-descriptive traits differing in valence (positive vs. negative) and social domain (power vs. affiliation).
b2. Response to emotional faces. b3. Anticipating and receiving monetary reward vs. loss.
Tel-Aviv Sourasky Medical Center
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06977087
Anxiety Disorders, Mental Disorders
Marburg, Germany
View Trial DetailsNCT07464158
Anxiety, Anxiety Disorders
Boulder, Colorado, United States
View Trial DetailsNCT06465589
Mental Disorders, Social Anxiety
Bern, Switzerland
View Trial DetailsNCT05996419
Social Anxiety
Charleston, South Carolina, United States
View Trial Details